Emergent BioSolutions Inc (NYSE:EBS)

54.37
Delayed Data
As of 4:02pm ET
 -0.71 / -1.29%
Today’s Change
28.28
Today|||52-Week Range
55.91
+17.00%
Year-to-Date

Today’s Trading

Previous close55.08
Today’s open55.00
Day’s range53.86 - 55.21
Volume228,372
Average volume (3 months)363,016
Market cap$2.6B
Data as of 4:02pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+51.33%
Earnings growth (this year)+18.55%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+14.75%
P/E ratio31.8
Price/Sales4.17
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.25-0.70%
LXRXLexicon Pharmaceutic...+0.06+0.73%
INVAInnoviva Inc+0.33+2.08%
MYOKMyoKardia Inc-1.20-2.40%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.29
Annual revenue (last year)$560.9M
Annual profit (last year)$82.6M
Net profit margin14.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
President &
Chief Operating Officer
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts